• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) JUVEDERM VOLUMA XC 27G 2 X 1ML; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) JUVEDERM VOLUMA XC 27G 2 X 1ML; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 94640
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Inflammation (1932); Irritation (1941)
Event Date 11/21/2017
Event Type  Injury  
Manufacturer Narrative
The event is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.A review of the device history record has been completed.  no deviations or non-conformances identified.This is a known potential adverse event addressed in the product labeling.Further information regarding event, product, or patient details has been requested.No additional information is available at this time.
 
Event Description
Healthcare professional (hcp) reported injecting a patient with 2ml of juvéderm voluma® xc in the cheeks and 0.4ml of juvéderm volbella® xc in the lips.About 6 weeks later, patient allegedly developed an ¿infection¿ in one of their cheeks.Patient is ¿not happy.¿ hcp reported ¿it did have some swelling and redness, but [they] didn't think it was an infection.Usually an infection would occur within 48-72hrs after a procedure, not 6 weeks.At 6 weeks, [they] put [the patient] on antibiotics (bactrim).¿ hcp told the patient to follow up 3-days later.Patient didn't come back for 2 weeks, which is when hcp administered hyaluronidase (about 2 months after the procedure).¿warmth¿ was also reported.A culture was done; results indicated no wbcs or bacteria.A ct scan without contrast was done and there was no fluid collection to suggest abscess.Hcp also recommended motrin as treatment and also provided incision and drainage.Symptoms resolved and patient was left with ¿scarring, loss of volume, and hyperpigmentation.¿.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JUVEDERM VOLUMA XC 27G 2 X 1ML
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR  74370
Manufacturer (Section G)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR   74370
Manufacturer Contact
michelle burgess
12331-a riata trace parkway
building 3
austin, TX 78727
7372473605
MDR Report Key9687574
MDR Text Key178534006
Report Number3005113652-2020-00044
Device Sequence Number1
Product Code LMH
UDI-Device Identifier30888628000012
UDI-Public30888628000012
Combination Product (y/n)Y
PMA/PMN Number
P110033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician Assistant
Type of Report Initial
Report Date 02/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/10/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/16/2019
Device Catalogue Number94640
Device Lot NumberVB20A70460
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/13/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Disability;
Patient Age76 YR
-
-